Your Trusted CDMO Partner

INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through
commercial phase sterile injectable drug products for the global biopharmaceutical market.Our facility is FDA-approved and Annex 1-compliant and uses the latest technology to provide
tailored manufacturing solutions. We fill high-value biologics and peptides into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics.

Our experienced team creates value for customers by decreasing manufacturing times and
simplifying complex supply chains, enabling drug developers to focus on advancing their therapies with confidence.

We aim to be a strategic CDMO partner for market-leading biopharmaceutical companies who are looking to collaborate across multiple programs over the long-term.

Our Journey

INCOG BioPharma was born on a 34-mile bike ride in Maui. Our founder, Cory Lewis, was between careers and unsure of what opportunity he wanted to pursue – but he knew he wanted to do something that had an impact. That was different, better and faster, and gave customers the experience they deserve. 

Somewhere between Paia and Mt. Haleakala, he realized what the answer was. Using his 20+ years of experience in the CDMO marketplace, his connections and associates, Cory set about to create a company that believes in making the world healthier while keeping patients’ best interests at heart. And so INCOG BioPharma was born.

Our Mission

We are on a mission to create better and more accelerated paths to market for your life-saving drugs by serving you in extraordinary ways.

We do this by cultivating a high-performance organization that serves your unique drug production requirements, fosters innovation and strives to do things differently by taking a flexible approach to every project we take on.

Our Facility

Based in the beautiful city of Fishers, Indiana, our world-class facility houses state-of-the-art equipment and robust quality processes that help us ensure unwavering compliance.